The largest database of trusted experimental protocols

Retroviral pgfp 5 rs vectors

Manufactured by OriGene
Sourced in United Kingdom

The Retroviral pGFP-V-RS vectors are a series of expression vectors designed for the production of high-titer retroviral particles. These vectors contain a GFP (green fluorescent protein) reporter gene and a shRNA (short hairpin RNA) expression cassette, allowing for the visualization of transduced cells and the targeted knockdown of gene expression, respectively.

Automatically generated - may contain errors

2 protocols using retroviral pgfp 5 rs vectors

1

Septin7 Silencing in C2C12 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
C2C12 cells were seeded in 6-well culture plates in DMEM containing 10% FBS. At 50–70% confluence, medium was replaced by serum-free OptiMEM and cells were transfected with Septin7-specific shRNA constructs in retroviral pGFP-V-RS vectors (Origene, Cambridge, UK) using Lipofectamine 2000 transfection reagent. For controls, a noneffective scrambled shRNA cassette vector was employed (Scr). 3 hr after transfection, the medium was replaced by complete DMEM, cells were allowed to recover and synthesize the coded shRNA for 48 hr. Puromycin (2 µg/ml)-containing medium was applied to select cells containing the specific shRNA sequences until well-defined cell clones were visible within the culture plates. Individual clones were then separated and cultured further to analyze the effective gene silencing by Western blot. Appropriate clones presenting significant Septin7 expression change were tested throughout increasing passage numbers, and continuously detectable lower Septin7 expression was required to use the cell clone for further investigation (S7-KD cells).
+ Open protocol
+ Expand
2

Plasmid-based shRNA Silencing of Septin7 in C2C12 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The modification of Septin7 expression in C2C12 cells was evaluated using the plasmid-based shRNA technique as described earlier [41 (link)]. Briefly, C2C12 myoblasts were transfected with Septin7-specific shRNA constructs in retroviral pGFP-V-RS vectors (Origene, Cambridge, UK) using Lipofectamine 2000 transfection reagent in serum-free OptiMEM (Life Technologies). For controls, an ineffective scrambled shRNA cassette vector was employed (Scr). Briefly, 48 h after transfection, a Puromycin (2 µg/mL)-containing medium was applied to select cells containing the specific shRNA sequences. Individual clones were then separated and cultured further to analyze the effective gene silencing via Western blotting. Appropriate clones presenting a significant Septin7 expression change were tested throughout increasing passage numbers, and continuously detectable lower Septin7 expression was required to use the cell clone for further investigation (S7-KD cells).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!